PSMB9 and lymphoma: Further utilizing the EBV antigens present within ENKTCL, stimulated cytotoxic T lymphocytes (CTL) directed at LMP1 and LMP2 within the virus have shown efficacy in treating a multitude of EBV-derived lymphomas (65).